Year |
Citation |
Score |
2012 |
Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, Ghosh A, Tsai JJ, Rao UK, Yim NL, Smith OM, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 37: 339-50. PMID 22921121 DOI: 10.1016/J.Immuni.2012.05.028 |
0.682 |
|
2011 |
Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, et al. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation. Plos One. 6: e21611. PMID 21760897 DOI: 10.1371/Journal.Pone.0021611 |
0.675 |
|
2011 |
Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, et al. Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood. 118: 446-55. PMID 21596854 DOI: 10.1182/blood-2010-07-294785 |
0.717 |
|
2010 |
Ghosh A, Holland AM, Kappel LW, Dogan Y, Yim N, Rao U, Smith OM, Jenq RR, Zakrzewski J, Na I-, Lu S, Tsai J, Penack O, Hanash A, Sauer MG, et al. Over-Expression Of Trail On Donor T Cells Simultaneously Ameliorates GVHD And Enhances GVT Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.434 |
0.68 |
|
2009 |
Rotolo JA, Stancevic B, Lu SX, Zhang J, Suh D, King CG, Kappel LW, Murphy GF, Liu C, Fuks Z, van den Brink MR, Kolesnick R. Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood. 114: 3693-706. PMID 19666872 DOI: 10.1182/Blood-2008-11-191148 |
0.715 |
|
2009 |
Jenq RR, King CG, Volk C, Suh D, Smith OM, Rao UK, Yim NL, Holland AM, Lu SX, Zakrzewski JL, Goldberg GL, Diab A, Alpdogan O, Penack O, Na IK, ... Kappel LW, et al. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood. 113: 1574-80. PMID 19011222 DOI: 10.1182/Blood-2008-05-155697 |
0.681 |
|
2009 |
Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood. 113: 945-52. PMID 18931341 DOI: 10.1182/Blood-2008-08-172155 |
0.709 |
|
2008 |
Kappel L, Goldberg G, Ivanov I, Na I, King C, Suh D, Smith O, Ligh C, Littman D, van den Brink M. 27: IL-17 is Required for CD4-Mediated GVHD Biology of Blood and Marrow Transplantation. 14: 12-13. DOI: 10.1016/J.Bbmt.2007.12.035 |
0.395 |
|
Show low-probability matches. |